CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $98.80 billion. The enterprise value is $167.35 billion.
| Market Cap | 98.80B |
| Enterprise Value | 167.35B |
Important Dates
The next confirmed earnings date is Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Oct 23, 2025 |
Share Statistics
CVS Health has 1.27 billion shares outstanding. The number of shares has decreased by -1.02% in one year.
| Current Share Class | 1.27B |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 87.31% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 21.70 and the forward PE ratio is 11.77. CVS Health's PEG ratio is 0.61.
| PE Ratio | 21.70 |
| Forward PE | 11.77 |
| PS Ratio | 0.26 |
| Forward PS | 0.24 |
| PB Ratio | 1.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.67 |
| P/OCF Ratio | 13.06 |
| PEG Ratio | 0.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.98, with an EV/FCF ratio of 35.01.
| EV / Earnings | 36.94 |
| EV / Sales | 0.44 |
| EV / EBITDA | 11.98 |
| EV / EBIT | 17.92 |
| EV / FCF | 35.01 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.07.
| Current Ratio | 0.80 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 4.88 |
| Debt / FCF | 17.31 |
| Interest Coverage | 3.05 |
Financial Efficiency
Return on equity (ROE) is 5.88% and return on invested capital (ROIC) is 3.66%.
| Return on Equity (ROE) | 5.88% |
| Return on Assets (ROA) | 2.29% |
| Return on Invested Capital (ROIC) | 3.66% |
| Return on Capital Employed (ROCE) | 5.69% |
| Revenue Per Employee | $1.28M |
| Profits Per Employee | $15,103 |
| Employee Count | 300,000 |
| Asset Turnover | 1.50 |
| Inventory Turnover | 19.88 |
Taxes
In the past 12 months, CVS Health has paid $2.01 billion in taxes.
| Income Tax | 2.01B |
| Effective Tax Rate | 30.89% |
Stock Price Statistics
The stock price has increased by +18.08% in the last 52 weeks. The beta is 0.61, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +18.08% |
| 50-Day Moving Average | 72.08 |
| 200-Day Moving Average | 64.63 |
| Relative Strength Index (RSI) | 66.24 |
| Average Volume (20 Days) | 6,800,759 |
Short Selling Information
The latest short interest is 18.94 million, so 1.49% of the outstanding shares have been sold short.
| Short Interest | 18.94M |
| Short Previous Month | 18.80M |
| Short % of Shares Out | 1.49% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 2.48 |
Income Statement
In the last 12 months, CVS Health had revenue of $384.33 billion and earned $4.53 billion in profits. Earnings per share was $3.59.
| Revenue | 384.33B |
| Gross Profit | 51.13B |
| Operating Income | 9.34B |
| Pretax Income | 6.50B |
| Net Income | 4.53B |
| EBITDA | 13.97B |
| EBIT | 9.34B |
| Earnings Per Share (EPS) | $3.59 |
Balance Sheet
The company has $14.17 billion in cash and $82.72 billion in debt, giving a net cash position of -$68.55 billion or -$54.05 per share.
| Cash & Cash Equivalents | 14.17B |
| Total Debt | 82.72B |
| Net Cash | -68.55B |
| Net Cash Per Share | -$54.05 |
| Equity (Book Value) | 77.55B |
| Book Value Per Share | 61.07 |
| Working Capital | -18.51B |
Cash Flow
In the last 12 months, operating cash flow was $7.57 billion and capital expenditures -$2.79 billion, giving a free cash flow of $4.78 billion.
| Operating Cash Flow | 7.57B |
| Capital Expenditures | -2.79B |
| Free Cash Flow | 4.78B |
| FCF Per Share | $3.77 |
Margins
Gross margin is 13.30%, with operating and profit margins of 2.43% and 1.18%.
| Gross Margin | 13.30% |
| Operating Margin | 2.43% |
| Pretax Margin | 1.69% |
| Profit Margin | 1.18% |
| EBITDA Margin | 3.64% |
| EBIT Margin | 2.43% |
| FCF Margin | 1.24% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.41%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.41% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 74.09% |
| Buyback Yield | 1.02% |
| Shareholder Yield | 4.43% |
| Earnings Yield | 4.59% |
| FCF Yield | 4.84% |
Analyst Forecast
The average price target for CVS Health is $80.12, which is 2.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $80.12 |
| Price Target Difference | 2.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 4.98% |
| EPS Growth Forecast (5Y) | 19.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 6 |